Is Virpax Pharmaceuticals, Inc. (VRPX) a Buy, Sell, or Hold?
OTC : VRPX
Virpax Pharmaceuticals, Inc. — Insider Trades
$0.0001 USD
$0 (0.0%)
- Volume
- 51
- Average Volume
- 410
- Market Capitalization
- $124
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $0.10
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.63
Insider Activity Summary (Last 12 Months)
Insiders Buying
26
Insiders Selling
3
Amount of Insider Selling
$197.68K
VRPX Insider Buying/Selling by Quarter
VRPX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Panis Jaydriane | director: | 2024-12-17 | 0 | 2025-01-08 | |
| Chaudhry Usama | officer | 2024-11-18 | 0 | 2025-01-06 | |
| Randhawa Esha | director: | 2024-11-19 | 0 | 2024-12-04 | |
| Su Judy | director: | 2024-07-05 | 0 | 2024-07-15 | |
| Field Katharyn | director | 2024-07-05 | A-Award | 0.578 | 2024-07-10 |
| Field Katharyn | director: | 2024-07-05 | 0 | 2024-07-10 | |
| Herman Gary L | director | 2024-07-05 | A-Award | 0.578 | 2024-07-09 |
| Dhaliwal Jatinder | director | 2024-07-05 | A-Award | 0.578 | 2024-07-09 |
| Herman Gary L | director: | 2024-07-05 | 0 | 2024-07-09 | |
| Dhaliwal Jatinder | director: | 2024-07-05 | 0 | 2024-07-09 | |
| Singh Vanila | director | 2024-01-29 | A-Award | 0.3178 | 2024-01-31 |
| Shah Vinay | officer: Chief Financial Officer | 2024-01-29 | A-Award | 0.3178 | 2024-01-31 |
| Jambulingam Thani | director | 2024-01-29 | A-Award | 0.3178 | 2024-01-31 |
| Mathias Sheila | officer: Chief Scientific Officer | 2024-01-29 | A-Award | 0.3178 | 2024-01-31 |
| Dubin Michael F | director | 2024-01-29 | A-Award | 0.3178 | 2024-01-31 |
| Sendrow Jerrold | director | 2024-01-29 | A-Award | 0.3178 | 2024-01-31 |
| Bruce Gerald W | director, officer: Chief Executive Officer | 2024-01-29 | A-Award | 0.3178 | 2024-01-31 |
| Floyd Eric | director | 2024-01-29 | A-Award | 0.3178 | 2024-01-31 |
| Ruskin Barbara | director | 2024-01-29 | A-Award | 0.3178 | 2024-01-31 |
| Mathias Sheila | officer: Chief Scientific Officer | 2024-01-25 | 0.79 | 2023-10-03 | |
| Mathias Sheila | officer: Chief Scientific Officer | 2023-01-31 | 2.13 | 2023-10-03 | |
| Mathias Sheila | officer: Chief Scientific Officer | 2022-04-07 | 4.62 | 2023-10-03 | |
| Shah Vinay | officer: Chief Financial Officer | 2023-06-20 | A-Award | 0.99 | 2023-06-21 |
| Shah Vinay | officer | 2023-06-20 | 0 | 2023-06-21 | |
| Bruce Gerald W | director | 2023-04-24 | A-Award | 0.73 | 2023-04-26 |
| Ruskin Barbara | director | 2023-03-24 | A-Award | 0.8364 | 2023-03-28 |
| Ruskin Barbara | director: | 2023-03-24 | 0 | 2023-03-28 | |
| Mack Anthony P. | director, 10 percent owner, officer: Chief Executive Officer | 2023-01-25 | A-Award | 0.867 | 2023-02-07 |
| Gudin Jeffrey | officer: Chief Medical Officer | 2023-01-25 | A-Award | 0 | 2023-01-27 |
| Mack Anthony P. | officer: Chief Executive Officer | 2023-01-25 | A-Award | 0 | 2023-01-27 |
| Chipman Christopher Michael | officer: Chief Financial Officer | 2023-01-25 | A-Award | 0 | 2023-01-27 |
| Jambulingam Thani | director | 2023-01-01 | A-Award | 0 | 2023-01-04 |
| Floyd Eric | director | 2023-01-01 | A-Award | 0 | 2023-01-04 |
| Sendrow Jerrold | director | 2023-01-01 | A-Award | 0 | 2023-01-04 |
| Dubin Michael F | director | 2023-01-01 | A-Award | 0 | 2023-01-04 |
| Singh Vanila | director | 2023-01-01 | A-Award | 0 | 2023-01-04 |
| Sendrow Jerrold | director: | 2022-05-24 | P-Purchase | 1.29 | 2022-05-26 |
| Mack Anthony P. | officer: Chief Executive Officer | 2022-05-18 | P-Purchase | 1.34 | 2022-05-20 |
| Floyd Eric | director: | 2022-05-18 | P-Purchase | 1.3635 | 2022-05-20 |
| Bruce Gerald W | director: | 2022-04-25 | A-Award | 0 | 2022-04-27 |
| Gudin Jeffrey | director, officer: Chief Medical Officer | 2022-01-31 | A-Award | 2.13 | 2022-02-25 |
| Mack Anthony P. | director, 10 percent owner, officer: Chief Executive Officer | 2022-01-31 | A-Award | 2.13 | 2022-02-25 |
| Chipman Christopher Michael | officer: Chief Financial Officer | 2022-01-31 | A-Award | 2.13 | 2022-02-25 |
| Mack Anthony P. | director, 10 percent owner, officer: Chief Executive Officer | 2022-01-31 | A-Award | 2.34 | 2022-02-02 |
| Gudin Jeffrey | director, officer: Chief Medical Officer | 2022-01-31 | A-Award | 2.13 | 2022-02-02 |
| Chipman Christopher Michael | officer: Chief Financial Officer | 2022-01-31 | A-Award | 2.13 | 2022-02-02 |
| Sendrow Jerrold | director | 2022-01-01 | A-Award | 3.43 | 2022-01-05 |
| Jambulingam Thani | director | 2022-01-01 | A-Award | 3.43 | 2022-01-05 |
| Singh Vanila | director | 2022-01-01 | A-Award | 3.43 | 2022-01-05 |
| Dubin Michael F | director | 2022-01-01 | A-Award | 3.43 | 2022-01-05 |
| Floyd Eric | director | 2022-01-01 | A-Award | 3.43 | 2022-01-05 |
| JACOB GARY S | director | 2022-01-01 | A-Award | 3.43 | 2022-01-05 |
| Sendrow Jerrold | director | 2021-11-22 | P-Purchase | 3.925 | 2021-11-24 |
| Mack Anthony P. | director, 10 percent owner, officer: Chief Executive Officer | 2021-11-18 | P-Purchase | 3.99 | 2021-11-22 |
| Dubin Michael F | director | 2021-07-26 | A-Award | 4.32 | 2021-08-05 |
| Bruce Gerald W | director | 2021-07-26 | 0 | 2021-08-05 | |
| Bruce Gerald W | director | 2021-04-04 | 4.62 | 2021-08-05 | |
| Bruce Gerald W | director | 2021-03-11 | 9.89 | 2021-08-05 | |
| Dubin Michael F | director: | 2021-07-26 | 0 | 2021-08-05 | |
| Gudin Jeffrey | director, officer: Chief Medical Officer | 2021-04-07 | A-Award | 4.62 | 2021-04-09 |
| Singh Vanila | director | 2021-04-07 | A-Award | 4.62 | 2021-04-09 |
| Jambulingam Thani | director | 2021-04-07 | A-Award | 4.62 | 2021-04-09 |
| Sendrow Jerrold | director | 2021-04-07 | A-Award | 4.62 | 2021-04-09 |
| Bruce Gerald W | officer | 2021-02-16 | 0 | 2021-04-09 | |
| Floyd Eric | director | 2021-04-07 | A-Award | 4.62 | 2021-04-09 |
| Chipman Christopher Michael | officer: Chief Financial Officer | 2021-04-07 | A-Award | 4.62 | 2021-04-09 |
| Mack Anthony P. | director, 10 percent owner, officer: Chief Executive Officer | 2021-04-07 | A-Award | 4.62 | 2021-04-09 |
| JACOB GARY S | director | 2021-04-07 | A-Award | 4.62 | 2021-04-09 |
| Jambulingam Thani | director | 2021-02-17 | P-Purchase | 7.16 | 2021-03-01 |
| JACOB GARY S | director | 2021-02-17 | P-Purchase | 6.789 | 2021-02-19 |
| Gudin Jeffrey | director, officer: Chief Medical Officer | 2021-02-16 | 0 | 2021-02-16 | |
| Gudin Jeffrey | director, officer: Chief Medical Officer | 2021-02-16 | 0 | 2021-02-16 | |
| Gudin Jeffrey | director, officer: Chief Medical Officer | 2021-05-22 | 9.89 | 2021-02-16 | |
| Virpax Pharmaceuticals LLC | 10 percent owner | 2021-02-16 | 0 | 2021-02-16 | |
| Singh Vanila | director | 2021-06-15 | 9.89 | 2021-02-16 | |
| Jambulingam Thani | director | 2021-01-01 | 9.89 | 2021-02-16 | |
| Sendrow Jerrold | director | 2021-02-16 | 0 | 2021-02-16 | |
| Sendrow Jerrold | director | 2021-05-01 | 9.89 | 2021-02-16 | |
| JACOB GARY S | director | 2021-04-26 | 9.89 | 2021-02-16 | |
| Bruce Gerald W | director | 2021-02-16 | 0 | 2021-02-16 | |
| Bruce Gerald W | director | 2021-03-11 | 9.89 | 2021-02-16 | |
| Floyd Eric | director | 2021-02-16 | 0 | 2021-02-16 | |
| Floyd Eric | director | 2021-01-01 | 9.89 | 2021-02-16 | |
| Chipman Christopher Michael | officer: Chief Financial Officer | 2021-02-16 | 9.89 | 2021-02-16 | |
| Mack Anthony P. | director, officer: Chief Executive Officer | 2021-02-16 | 0 | 2021-02-16 | |
| Mack Anthony P. | director, officer: Chief Executive Officer | 2021-02-16 | 0 | 2021-02-16 | |
| Mack Anthony P. | director, officer: Chief Executive Officer | 2021-05-22 | 9.89 | 2021-02-16 |